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ABSTRACT Ca2þ/calmodulin-dependent protein kinase II (CaMKII) plays an important role in L-type Ca2þ channel (LCC) facil-
itation: the Ca2þ-dependent augmentation of Ca2þ current (ICaL) exhibited during rapid repeated depolarization. Multiple mech-
anisms may underlie facilitation, including an increased rate of recovery from Ca2þ-dependent inactivation and a shift in modal
gating distribution from mode 1, the dominant mode of LCC gating, to mode 2, a mode in which openings are prolonged. We
hypothesized that the primary mechanism underlying facilitation is the shift in modal gating distribution resulting from CaMKII-
mediated LCC phosphorylation. We developed a stochastic model describing the dynamic interactions among CaMKII, LCCs,
and phosphatases as a function of dyadic Ca2þ and calmodulin levels, and we incorporated it into an integrative model of the
canine ventricular myocyte. The model reproduces behaviors at physiologic protein levels and allows for dynamic transition
between modes, depending on the LCC phosphorylation state. Simulations showed that a CaMKII-dependent shift in LCC distri-
bution toward mode 2 accounted for the ICaL positive staircase. Moreover, simulations demonstrated that experimentally
observed changes in LCC inactivation and recovery kinetics may arise from modal gating shifts, rather than from changes in
intrinsic inactivation properties. The model therefore serves as a powerful tool for interpreting ICaL experiments.
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With each beat of the heart, cardiac myocyte contraction
and relaxation occur in response to a series of events that
are initiated and coordinated by the cardiac action potential
(AP). Membrane depolarization during the upstroke of the
AP activates voltage-gated L-type Ca2þ channels (LCCs),
triggering Ca2þ influx across the sarcolemma. This influx
of Ca2þ triggers Ca2þ release from the sarcoplasmic retic-
ulum (SR), providing the necessary signal to initiate
mechanical shortening of the cell.
A number of the proteins involved in this highly coordi-
nated process of cardiac excitation-contraction coupling
(ECC) are known to be modulated by Ca2þ/calmodulin-
dependent protein kinase II (CaMKII) (1,2). CaMKII phos-
phorylates a number of proteins involved in ECC, including
LCCs, ryanodine receptors (RyRs), and phospholamban
(PLB). The large number of potential ECC-related CaMKII
targets makes it difficult to quantify how phosphorylation
of each target contributes to the integrative properties of
ECC and myocyte function. In addition, altered function of
the CaMKII signaling pathway is thought to shape the
cellular phenotype of heart failure (HF) (3–6). Acute overex-
pression of CaMKII in isolated rabbit ventricular myocytes
results in increased Ca2þ spark frequency and enhanced
frequency-dependent acceleration of relaxation (7). In trans-
genic mice, elevated CaMKII activity significantly increases
action potential duration, decreases twitch shortening, and
leads to dilated cardiomyopathy (8).
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0006-3495/09/03/1770/16 $2.00Studies have shown that CaMKII expression level and
activity are increased in human cardiac myocytes from
patients with dilated cardiomyopathy (9,10). The relation-
ship between increased CaMKII levels and HF remains
unclear. Simulations by Tanskanen et al. (11) predicted
that phosphorylation-induced changes in LCC gating,
similar to those caused by CaMKII-mediated LCC phos-
phorylation, increase the likelihood of early after-depolariza-
tions (EADs). Anderson et al. (3) demonstrated that
inhibition of CaMKII activity significantly decreased likeli-
hood of EADs in rabbit hearts. It is possible that CaMKII
alters the rate of L-type Ca2þ current (ICaL) restitution,
thereby increasing the probability of EAD initiation. It is
likely that abnormal CaMKII levels also modulate ICaL facil-
itation, the Ca2þ-dependent augmentation of ICaL observed
as a positive staircase in current amplitude in conjunction
with a progressively slowed rate of current inactivation,
which manifests during rapid repeated depolarizing stimuli.
ICaL facilitation alters the behavior of LCCs under conditions
of rapid pulsing, a condition that likely occurs during tachy-
arrhythmia or fibrillation, and has the potential to signifi-
cantly alter AP shape and duration.
Many CaMKII inhibitor experiments have demonstrated
that physiological ICaL facilitation is the functional result of
CaMKII-mediated events (12–15). Single-channel experi-
ments have shown that CaMKII phosphorylation of LCCs
results in increased channel open probability (16). More-
over, mutation studies of CaMKII-specific LCC phosphor-
ylation sites have demonstrated that CaMKII-mediated
phosphorylation of LCCs is required for ICaL facilitation
(17,18). Multiple mechanisms may underlie changes in
properties of ICaL associated with facilitation. It has been
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from Ca2þ-dependent inactivation (CDI) underlies facilita-
tion (15,19,20). An alternate hypothesis is that a shift in the
distribution of LCCs into high-activity gating modes under-
lies facilitation (16). LCC gating modes are recognized
discrete gating patterns. Mode 1 is the dominant form of
LCC gating, and it is characterized by repeated brief open-
ings. Mode 2 is a high-activity gating mode characterized
by prolonged channel openings (21). However, it is difficult
to experimentally dissect the distinct fundamental mecha-
nisms of CaMKII-mediated LCC phosphorylation associ-
ated with ICaL facilitation, because these mechanisms
would be triggered by the same signal, i.e., an elevated
local concentration of Ca2þ. Changes in either the modal
distribution of LCC openings or the magnitude of CDI
are closely coupled via alterations in local Ca2þ levels,
and both of these phenomena can result in increased ICaL.
We hypothesize that the phosphorylation-dependent shift
in LCC modal gating distribution from mode 1 to mode 2
is the primary mechanism underlying the hallmarks of
ICaL facilitation, namely, ICaL amplitude augmentation,
the apparent macroscopic increase in the rate of recovery
from inactivation, and an observed slowing of the inactiva-
tion rate of whole-cell ICaL. This hypothesis was tested by
interpreting existing experimental data in the context of
a previously validated model (22). The dynamic interac-
tions among CaMKII, LCCs, phosphatases, and dyadic
Ca2þ levels were modeled in the context of the canine
ventricular myocyte, thus allowing us to gain a further
understanding of the mechanisms underlying macroscopic
phenomena such as ICaL facilitation that would otherwise
be difficult to obtain from experimental observations alone.
To do this, we have developed a biochemically detailed,
stochastic model describing: 1), transitions between activity
states in individual CaMKII monomers; 2), dynamic phos-
phorylation and dephosphorylation of LCCs, mediated by
CaMKII and phosphatases; and 3), LCC voltage- and
Ca2þ-dependent gating. Over the past 15 years, in vitro
kinetic studies (23–25), cell-based assays (7), and transgenic
mouse studies (8) have been used to investigate the structure
and function of CaMKII under various conditions. A number
of groups have formulated multistate CaMKII models that
replicate in vitro experimental results and accurately describe
the CaMKII state as a function of Ca2þ and calmodulin
(CaM) concentration (26–28). In addition, others have devel-
oped models of CaMKII action within its physiologic envi-
ronment in attempting to elucidate the role of CaMKII in
neurons (29) and cardiac myocytes (30–32). The model pre-
sented here is based on this prior work, but it has been
extended to reproduce integrative behaviors of CaMKII and
LCCs at physiologic protein levels in cardiac myocytes. An
additional novel feature of this new model is that it allows
for dynamic transition of individual LCCs between gating
modes, which occurs as a function of the phosphorylation
state of the channel.The model of CaMKII monomer activity is based on that
created previously by Dupont et al. (26), which has been
shown to faithfully reproduce dynamic in vitro experimental
results on CaMKII activation. The model has been extended
to include dephosphorylation reactions and two additional
CaMKII activity states relating to phosphorylation at the
CaM binding site. The model of CaMKII-mediated LCC
phosphorylation is based on biochemical studies (17,18). It
is coupled with a modified version of a Markov state model
of the LCC, which accurately reproduces single-channel
experimental results, and this model has been validated
against whole-cell findings after incorporating it into an inte-
grative computational model of the canine ventricular myo-
cyte (22). Model results suggest that a CaMKII-dependent
shift in LCC modal distribution is sufficient to account for
increased ICaL amplitude, the apparent macroscopic increase
in the rate of recovery from inactivation, and the slowing of
the inactivation rate observed experimentally.
METHODS
The CaMKII-LCC model
The complete model described in this work is referred to as the CaMKII-
LCC model. It consists of three modules: the CaMKII activity model,
the LCC phosphorylation model, and the LCC gating model. The CaM-
KII-LCC model is formulated to describe local interactions between indi-
vidual CaMKII and LCC molecules.
Electron microscopy imaging and crystal structure analysis have shown
that CaMKII monomers (subunits) join together to form a dodecameric
holoenzyme (33–35). In addition, biochemical analysis has revealed that
CaMKII tethers to the LCC and acts as an integrator of local Ca2þ signaling
(36). The CaMKII-LCC model assumes that there is one 12-subunit holoen-
zyme tethered to each LCC, as proposed by Hudmon et al. (36).
The space in which CaMKII molecules and LCCs interact is a microdo-
main known as the dyad. Each dyad has a height of ~15 nM and a diameter
of ~100 nM, as illustrated in Fig. 1. There are several thousand dyads posi-
tioned along the network of T-tubular membrane in each cardiac myocyte.
The local control theory of ECC states that the opening of one or a few
LCCs at a particular location in the T-tubular membrane triggers Ca2þ
release from a small cluster of nearby RyRs in the closely apposed junctional
SR membrane (37,38). LCCs and RyRs are sensitive to local Ca2þ levels. In
the CaMKII-LCC model, each module described the dynamic transitions
among states of an individual CaMKII or LCC molecule in the cardiac
dyad and was simulated stochastically. All modules have been integrated
into the local control canine ventricular myocyte model of Greenstein and
Winslow (22).
The CaMKII activity module is based on the model of Dupont et al. (26),
which describes the activity of CaMKII as a function of Ca2þ and CaM
concentrations, and it accurately reproduced results from in vitro kinase
assays (23). Their five-state deterministic model has been modified by im-
plementing it within a stochastic framework that is constrained by the geom-
etry of a CaMKII holoenzyme. This was accomplished by restricting
CaMKII autophosphorylation events to occur only between adjacent CaM-
KII subunits. This change had no significant effect on simulated average
in vitro CaMKII activity (see Supporting Material). The model was further
modified by the addition of two more physiologic states: the capped state C,
in which CaMKII is phosphorylated at both T287 and T306 (CaM binding
site), and the additional inactive state U, in which CaMKII is phosphorylated
only at T306, as described in Hudmon and Schulman (39). It has been shown
that protein phosphatases 1 (PP1) and 2a (PP2A) are primarily responsible
for dephosphorylating CaMKII sites T287 (36,40,41) and T306 (42),
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the CaMKII activity model presented here.
Fig. 2A illustrates the CaMKII activity model, which reflects the different
structural and functional states of the kinase, as described in Hudmon and
Schulman (39). CaMKII molecules each have a catalytic, a regulatory,
and an association domain. When the regulatory domain folds over the
FIGURE 1 Schematic representation of the cardiac dyad. Ca2þ ions pass
through the LCC and enter the dyad, where they bind to RyRs, triggering
their opening and leading to Ca2þ release from the SR. A CaMKII holoen-
zyme is tethered to each LCC, and the activity of each CaMKII monomer is
a function of dyadic Ca2þ levels. Ca2þ ions released from the SR diffuse out
of the dyad into the bulk myoplasm.catalytic site, the kinase inhibits its own activity and is unable to phosphor-
ylate its targets. This is called the inactive state, corresponding to state I.
Autoinhibition is eliminated when Ca2þ-bound calmodulin (Ca/CaM) binds
to the regulatory domain, thus exposing the catalytic site. This bound config-
uration is represented by state B. CaMKII is considered to be ‘‘active’’ in this
state. When CaMKII is phosphorylated at T287 by an adjacent molecule in
the CaMKII holoenzyme, its affinity for CaM and its kinase activity both
increase. This phosphorylated configuration corresponds to state P. While
it is phosphorylated at T287, a decrease in Ca2þ concentration will allow
the bound Ca2þ to unbind, leaving CaMKII in a state that remains active
(state T), although at a lower level of activity than that in state P. Even if
CaM is released while T287 is phosphorylated (state A), CaMKII remains
active. Once the kinase occupies state A, it rapidly phosphorylates itself
at the binding site T306, preventing Ca2þ/CaM from binding again. This
‘‘capped’’ state, represented by state C, is far less catalytically active than any
other active state (43). CaMKII remains in this dual phosphorylated active
state until T287 is dephosphorylated by PP1, at which point it occupies
the inactive state U. CaMKII returns back to state I upon dephosphorylation
at site T306. It should be noted that the transition from inactive state I to U is
a possible but rare occurrence, through a very slow autophosphorylation
reaction (42).
The T287 dephosphorylation rate was derived by converting the specific
activity of purified PP1 from 25,000 units of substrate phosphate/mg/min
(New England Biolabs, Ipswich, MA) to a rate of 0.01561 molecules of
substrate phosphate/molecule of PP1/ms. To constrain the concentration of
PP1, the height of the dyadic cleft was considered (15 nM (37)). Because
of the very small distance between LCCs and RyRs, it was assumed that
a PP1 molecule tethered to each RyR (44,45) apposing the LCC would be
able to contribute to the dephosphorylation of CaMKII. In the Greenstein
and Winslow model (22), the RyR/LCC ratio is 5:1 in each dyad. Therefore,
in our model, 5 PP1 molecules acted to dephosphorylate the 12 CaMKII
subunits in each holoenzyme. Using this rate of dephosphorylation and
CaMKII/PP1 stoichiometry in model simulations, only ~4% of CaMKII
was autophosphorylated during 2-Hz pacing (see Fig. S3 in the Supporting
Material). This is consistent with the negligible level of CaMKII autophos-
phorylation measured in response to high-frequency pacing in rat ventricularFIGURE 2 State diagrams for the CaMKII, LCC, and
CaMKII-LCC modules. (A) State model of the activation
and deactivation processes of the CaMKII activity module.
Transition rates for individual CaMKII monomers are
modeled as a function of Ca2þ levels, CaM, and phospha-
tase in the dyad and as a function of the activity of neigh-
boring CaMKII subunits in the holoenzyme. States that are
shaded in are active. (B) State model of the CaMKII-LCC
phosphorylation module. Higher CaMKII activity trans-
lates into higher phosphorylation rates, thus promoting
transition from the left-to-right states. Dephosphorylation
is a fixed rate, modeled on PP2A activity and concentra-
tion. If a channel is phosphorylated at all three sites
(shaded), it gates in mode 2. (C) State model of the voltage
activation processes of the LCC channel module (22).
Depolarization promotes transitions from left to right
toward open states. Elevation of Ca2þ promotes CDI.
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it dephosphorylates the LCC. In the model, all PP2A dephosphorylation
rates were assumed to be equal. A description of the data used to constrain
these rates can be found in the explanation of the LCC phosphorylation
model.
Ca2þ/CaM binding and autophosphorylation each affect the conformation
of CaMKII and influence the degree to which its catalytic subunit is exposed.
As a result, CaMKII phosphorylates its targets at different rates, depending
on its state. Following the method of Dupont et al. (26), we defined an
activity coefficient associated with each conformation, which represents
the state’s phosphorylation rate normalized to the maximum phosphorylation
rate of CaMKII. These coefficients are listed in Table 1. The ‘‘activity’’ of
a CaMKII molecule refers to the activity coefficient associated with its
current state. The activity of a CaMKII holoenzyme, CaMKIIHoloAct, is
defined as the average of the activities of its 12 subunits. This value was
used to determine the phosphorylation rate of its associated LCC within
each dyad.
Fig. 2 B illustrates the structure of the four-state Markov LCC phosphory-
lation model. In the figure, iP refers to the state in which i sites are phosphor-
ylated. This model is based on mutation studies (17,18) indicating that LCCs
undergo complete facilitation if and only if they are phosphorylated at each of
three distinct sites (T498 on the b-subunit and S1512 and S1570 on the
a-subunit). Using various peptide substrates, White et al. (46) determined the
optimal recognition motif of CaMKII. It consists of hydrophobic amino acids
at positions5 andþ1, arginine at position3, and a nonbasic amino acid at
position 2 (where positions are given with respect to the serine/threonine
phosphorylation site). It was observed that if these critical sites were varied,
CaMKII Vmax/Km decreased significantly. Because all three phosphorylation
sites on the LCC are part of such optimally recognizable consensus sequences,
the rate of phosphorylation of each LCC site was assumed to be equal, and was
assumed to vary as a function of the average CaMKII activity of the attached
holoenzyme. Currently, there are no additional data available regarding the
rate of phosphorylation at these sites. The maximum phosphorylation rate of
each LCC site (KPhos) is assumed to be equal to the phenomenologic rate
constant for phosphorylation, KBToP, used by Dupont et al. (26).
It has been shown that PP2A is tethered to the LCC (47) and that this
phosphatase is responsible for mediating mode 2 gating resulting from
protein kinase A (PKA)-mediated phosphorylation (48). We assumed that
PP2A also dephosphorylates the three CaMKII-mediated phosphorylation
sites on the LCC described above. We performed a parametric analysis
and set the rate of dephosphorylation (KDephos) equal to a fraction of the
maximum dephosphorylation rate reported by PP2A distributors (Gentaur,
Brussels, Belgium), to obtain ~15% increase in peak ICaL at 2-Hz pacing,
as seen in rabbit ventricular myocytes (15). Because experimental data has
shown that CaMKII and PP2A are tethered to LCCs, the model assumes
that a single CaMKII holoenzyme and a single PP2A molecule are always
bound to the LCC, and, therefore, it does not account for binding reactions
among the kinase, phosphatases, and channel. If an LCC is phosphorylated
at all three sites, i.e., if the associated CaMKII-LCC phosphorylation model
occupies state 3P, then it operates in mode 2. Otherwise, the LCC operates in
mode 1. It was assumed that LCC phosphorylation occurs independently of
voltage- and Ca2þ-dependent gating.
TABLE 1 CaMKII activity coefﬁcients
Parameter Value Reference
CI 0 (26)
CB 0.75 (26)
CP 1 (26)
CT 0.8 (26)
CA 0.8 (26)
CC 0.17 (43)
CU 0 (42)
Cx is the relative CaMKII activity in state x.Fig. 2 C displays the 12-state Markov LCC gating model, originally
developed by Jafri et al. (49) and later modified in the Greenstein and Win-
slow canine ventricular myocyte model (22). In this model, LCCs undergo
voltage- and Ca2þ-dependent gating. States 1–6 are ‘‘mode normal,’’
meaning that there is no inactivation by bound Ca2þ/CaM, and states
7–12 are ‘‘mode CDI,’’ which denotes channel binding by Ca2þ/CaM. States
1–5 are normal mode closed states. Forward and reverse transition rates
among these states are voltage dependent. State 6 is the mode normal
open state. The parameters f and g describe the transition rates between states
5 and 6, and they are voltage independent. States 7–11 are mode CDI closed
states. The transition rates among these states are voltage dependent. State
12 is open and in mode CDI. It is very rare for a channel to occupy state
12, because the constant transition rate between states 11 and 12 (f0) is
very small. The transition rates from normal mode closed states 1–5 to
mode CDI states 7–11 increase with subspace [Ca2þ], whereas the reverse
rates are constant. Independent of these transitions, channels also undergo
voltage-dependent inactivation (VDI), a process that is more than an order
of magnitude slower than the rates with CDI (50,51). For a channel to be
open, it must occupy state 6 or 12, and it must not be voltage inactivated.
The LCC gating model reflects two forms of channel gating, mode 1
and mode 2, which are distinguished by their mean open time. In
single-channel studies on isolated murine ventricular myocyte LCCs,
Dzhura et al. (16) demonstrated that phosphorylation of channels by
constitutively active CaMKII results in a shift to mode 2 gating. They
also showed that the mean open time for channels in mode 2 is ~20 times
longer than that in mode 1. We use the original Greenstein and Winslow
LCC model (22) to characterize mode 1, because it has been shown to
accurately describe this form of gating. In our model, mode 2 gating is
assumed to be identical to that of mode 1, except for a 20-fold reduction
in the rate of channel closing from the mode normal open state, to reflect
the difference in mean open time (transition rate g). Channels have the
ability to shift dynamically between modes 1 and 2, based on their phos-
phorylation state, which is characterized in the LCC phosphorylation
model. The phosphorylation state of the LCC is checked at all time steps
while the LCC is open, and if it is in the fully phosphorylated state 3P
(corresponding to all three sites phosphorylated), then the rate g is reduced
20-fold. This implementation allows the channel to be in either mode 1 or
mode 2 (fully phosphorylated) and to be in either mode normal (not
calcium inactivated) or in CDI. It will therefore be possible for some chan-
nels to be in both mode 2 and in CDI. It is important to emphasize that CDI
channels have identical rates whether in mode 1 or mode 2, and, therefore,
there is no real distinction between modes 1 and 2 while in CDI. The rate
g0 has not been altered in mode 2 channels, simply because this would
have virtually no significant effect, because the CDI open state (state
12) is virtually never occupied. Single-channel studies that characterize
properties of mode 1 versus mode 2 LCCs are typically performed in envi-
ronments in which CDI does not occur. There is therefore no evidence to
suggest how mode 1 and mode 2 channel gating properties may differ
upon CDI, and, therefore, it has been assumed that there is no difference.
It should be clarified that phosphorylation of the channel does not activate
it; phosphorylation serves only to reduce the rate of channel closing.
Therefore, if a channel is Ca2þ-inactivated (i.e., already closed) and phos-
phorylated, then the phosphorylation will not have any effect unless the
channel recovers from its CDI state and occupies an open state. A list
of frequently used variable names can be found in Table 2. Detailed equa-
tions and parameters describing the CaMKII-LCC model can be found in
the Appendix.
Whole-cell model
The CaMKII-LCC model was integrated into the canine ventricular myocyte
model of Greenstein and Winslow (22). Briefly, this model stochastically
simulates the local interactions of individual LCCs with apposing RyRs,
and now with CaMKII molecules, and embeds these simulations within
the numerical integration of differential equations describing ionic and
membrane pumps, exchangers and currents, Ca2þ cycling, and time-varying
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the Mersenne Twister algorithm was employed as the random number gener-
ator, as described in Tanskanen et al. (52). A typical simulation involves an
ensemble of 1000 dyads.
RESULTS
Single-channel experiments
Our central hypothesis is that the phosphorylation-dependent
shift in LCC modal gating distribution from mode 1 to mode
2 is the primary mechanism underlying ICaL amplitude
augmentation, the apparent macroscopic increase in the
rate of recovery from inactivation, and an observed slowing
of the inactivation rate of whole-cell ICaL. It is therefore
important to confirm that the modified LCC model presented
here is consistent with single-channel experimental data.
Experiments performed by Dzhura et al. (16) confirmed
that CaMKII-mediated phosphorylation of LCCs results in
a modal shift that increases the number of channels gating
in mode 2. In these experiments, a voltage clamp was applied
to LCCs in excised inside-out patches, in the presence of
different bath solutions. In one set of trials, the channels
were exposed to constitutively active, Ca2þ-independent
CaMKII that was phosphorylated at the T287 site; in another
set of trials, CaMKII was absent from the bath. Membrane
potential was held at70mV for 1800ms, followed by depo-
larization to a test clamp potential of 0mV for 200ms. Single-
channel openings were recorded during each test clamp.
Statistics of measured channel open times in these exper-
iments indicate that with constitutively active CaMKII
present, 50% of the channels gated in mode 2 and 50% gated
in mode 1, from which it can be assumed that one half of the
LCCs were phosphorylated at all of the CaMKII-mediated
sites and that the remaining LCCs were not. This is a plau-
sible assumption, because it is possible that during some
CaMKII experiments, LCCs were exposed to suboptimal
levels of active kinase, resulting from incomplete thiophos-
phorylation of CaMKII in the generation of constitutively
active kinase. (It was reported that Ca/CaM-independent
CaMKII activity was 35–50% of the total activity, and this
activity level persisted at >75% of initial levels during the
course of the experiments.) It is also possible that protein
TABLE 2 Frequently used variable names and abbreviations
Variable name/abbreviation Definition
CaMKII Calmodulin kinase II
LCC L-type Ca2þ channel
RyR Ryanodine receptor
CaM Calmodulin
PP1 Protein phosphatase 1
PP2A Protein phosphatase 2A
[Cacleft] Ca
2þ concentration in the dyad
CX CaMKII activity coefficient of state X
CaMKIIHoloAct Average CaMKII activity over the
holoenzyme
KXToY Transition rate from state X to state Y
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excised patches. The activity of these phosphatases would
serve to counteract phosphorylation by CaMKII on LCCs.
Fig. 3 illustrates results from isolated simulations, in
which the CaMKII-LCC model was decoupled from the
ventricular myocyte model. Fig. 3 A displays a histogram
of LCC open durations calculated from 200 single-channel
voltage clamp sweeps that were simulated in the presence
of constitutively active CaMKII and in the absence of phos-
phatases and Ca2þ (because EGTA was present in the bath
in experiments). Model results reproduced experimental
findings with a mean open time of ~10 ms. It should be noted
FIGURE 3 CaMKII-LCC phosphorylation model results. As in single-
channel studies performed in (16), LCCs were hyperpolarized to 70 mV
for 1800 ms, and then depolarized to 0 mV for 200 ms. (A) Single- channel
open times after exposure to constitutively active CaMKII. Histogram: simu-
lation results; curve: experimental fit, as described in (16). (B) Simulation
results of open probabilities for individual sweeps before and after the addi-
tion of constitutively active CaMKII at sweep 201. Measurements were
obtained during the depolarization period of the voltage clamp.
A Mechanistic Model of ICaL Facilitation 1775that the lack of Ca2þ precludes CDI and, consequently, more
channel openings occur under these conditions than would
be expected under physiological conditions.
Fig. 3 B shows results from a simulation in which 400
consecutive voltage clamp sweeps are applied to the LCC.
The first 200 sweeps occur in the absence of CaMKII, and
then constitutively active CaMKII is added to the bath before
sweep No. 201. After the addition of CaMKII, a large frac-
tion of sweeps exhibit a channel open probability that
exceeds 60%, which is consistent with experimental results
of Dzhura et al. (16). If the experiments of Dzhura et al.
(16) are interpreted to indicate that exposure to CaMKII
leads to a distribution of 50% of LCCs operating in mode
1 and 50% operating in mode 2, then the open probability
of LCCs in the presence of CaMKII should equal the average
of the open probabilities of mode 1 and mode 2 LCCs. The
simulated open probability was found to be 7.88% when
CaMKII was absent and 50.08% when it was present. The
mean open probability was 28.98%, which agrees well with
the experimentally obtained value of 25% (16).
ICaL pulse experiments
Pacing experiments in rabbit (7,12,15), mouse (16), and rat
(14,19) cardiac myocytes have indicated that CaMKII must
be active for LCC facilitation to occur. After rest, when
ventricular myocytes are repetitively depolarized at rates of
1–2 Hz, peak ICaL increases in a staircase-like manner after
the first pulse and reaches a steady state, with a peak ampli-
tude remaining at least 10% higher than that of the first pulse
until pacing ceases. However, when CaMKII-specific inhib-
itors such as AIP or KN-93 are applied, this positive staircase
effect is eliminated.
We have been able to reproduce these results accurately in
the model by employing the voltage clamp protocol used by
Guo and Duff (19). The membrane is hyperpolarized to
a holding potential of 80 mV for 60 s before pacing.
Each pulse then consists of a 40-mV prepulse of 100-ms
duration, followed by a 0-mV clamp of 200-ms duration.
Fig. 4, A and B display simulation results of peak ICaL as
a function of pulse number at 1 Hz and 2 Hz pacing, respec-
tively, in the presence and absence of CaMKII. Fig. 4 A
shows that, at 1-Hz pacing in the CaMKII-LCC model, facil-
itation is evident by the third pulse and is maintained for the
duration of the protocol. Steady-state facilitation is achieved
by the fifth pulse, and it remains at ~22% for the duration of
the protocol. In the absence of CaMKII, there are no mode 2
channels represented in the model, and, as expected, frac-
tional current remains close to unity through the pulse train.
Fig. 4 B illustrates the effects of two opposing phenomena
on LCCs, namely 1), Ca2þ- and voltage-dependent inactiva-
tion and 2), CaMKII phosphorylation, which leads to mode 2
gating. At 2 Hz, in the absence of CaMKII, the simulation
clearly exhibits a negative staircase effect, consistent with
experimental results in the presence of CaMKII inhibitors(15,19). Fig. 4 C displays the averaged simulation currents
for the first eight pulses in the 2-Hz pacing protocol
(n ¼ 30). The kinetic properties of the averaged first-pulse
currents are nearly identical, with peak values of 3.76 pA/pF
and 3.74 pA/pF in the presence and absence of CaMKII,
respectively. However, during the subsequent pulses, peak
ICaL decreases in simulations in the absence of CaMKII,
whereas it increases when CaMKII is present. Steady state
is achieved by the fifth pulse and maintained for the duration
of the protocol. At the fifth pulse, ICaL peaks at 4.88 pA/pF in
the presence of CaMKII, compared to a peak of 3.17 pA/pF
when CaMKII is absent. Steady-state facilitation at 2-Hz
pacing in the presence of CaMKII is ~15%.
The negative staircase exhibited in the absence of CaMKII
can be attributed to the LCC inactivation process. There is
a slight increase in the amount of CDI over the duration of
the protocol (66% at the end of the first pulse compared to
70% at the end of the twentieth pulse, data not shown).
More significantly, rapid pacing precludes complete
recovery from VDI between pulses, resulting in fewer chan-
nels available for opening (Fig. 4 D). One hundred percent of
channels were available at the start of the first pulse, whereas
incomplete recovery from VDI led to a reduction in LCC
availability to 85% at the beginning of subsequent pulses.
Despite of the fact that fewer LCCs were available during
pulses subsequent to pulse one, a positive staircase effect
was evident in the presence of CaMKII, because there was
a gradual increase in the fraction of mode 2 channels as
a consequence of LCC phosphorylation. This shift to mode
2 provided an increase in open probability that overcame
the decrease in availability due to incomplete recovery
from VDI, and the net result was ICaL facilitation. To under-
stand how channels redistribute themselves between modes
over time, Fig. 4 E presents the fraction of all LCCs that
are open versus the fraction of all LCCs that are both open
and in mode 2 during the 2-Hz pulse train. Whereas there
are nearly no mode 2 channels open during the first pulse,
by the fifth pulse, 4% of channels are open and gating in
mode 2. This fraction constitutes more than one third of all
open channels at peak ICaL (only 11% of LCCs are open)
and more than one half of all open channels during the late
phase of ICaL. As a result of the long open duration and,
hence, high open probability of mode 2 LCCs, a small shift
in the distribution of LCCs from mode 1 to mode 2 can
greatly increase the overall open probability and, therefore,
ICaL amplitude, for the combined population of LCCs.
Fig. 4 F shows the rapid rise in CaMKII activity, which is
responsible for the phosphorylation of LCCs. Only a small
fraction of this activity represents autophosphorylated states
independent of Ca2þ levels (~4% of all CaMKII molecules
are autophosphorylated; see Supporting Material), whereas
the overwhelming majority of the CaMKII activity arises
in response to the cycling of Ca2þ concentration levels in
the dyad. Fig. 4, G and H display the fraction of LCCs gating
in mode 2 during 1-Hz and 2-Hz pacing, respectively. At
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protocol was employed, as in (19), in which a prepulse of
40 mV was delivered, followed by a 200-ms depolariza-
tion to 0 mV. Holding potential was 80 mV. Twenty
consecutive pulses were delivered during each trial, and
30 trials were performed for each experimental simulation
(n ¼ 30). Results in the presence and absence of CaMKII
are presented. (A and B) Average results of peak ICaL at
1Hz- and 2-Hz pacing, respectively, normalized to the
peak ICaL of the first pulse in the trial. Bars are mean 
SE. (CF) Results from the 2-Hz pacing protocol, taken
from model simulation results in the presence of CaMKII:
(C) Average ICaL over the first 4 s. (D) Average percent of
LCCs not voltage inactivated over the first 6 s. (E) Time
course of percent of total open LCCs (solid line) and
percent of open LCCs in mode 2 only (filled section) during
the first 4 s. (F) Average CaMKII activity over all CaMKII
monomers during the first 6 s. (G) Fraction of LCCs gating
in mode 2 during 1-Hz pacing. (H) Fraction of LCCs gating
in mode 2 during 2-Hz pacing.steady state, the fraction of total LCCs gating in mode 2 is
8.9% during 1-Hz pacing and 9.5% during 2-Hz pacing.
Although a larger fraction of LCCs is gating in mode 2
during 2-Hz pacing, steady-state facilitation is lower than
that at 1-Hz pacing because, at most, 85% of channels
recover from VDI after the first depolarization (Fig. 4 F).
LCC inactivation
In rabbit adenoviral overexpression studies, Kohlhaas et al.
(7) demonstrated that myocytes with a six-fold increase in
CaMKII expression level display significantly slower ICaL
inactivation compared to that displayed by control myocytes.
Maier et al. (8) made similar observations in transgenic
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seem to contradict other studies (19) that show evidence
that there is no change in CDI in the presence of CaMKII
and thapsigargin, which eliminates facilitation by signifi-
cantly reducing SR Ca2þ load and, hence, subspace Ca2þ,
thereby reducing, but not eliminating, CaMKII activation.
Based on voltage clamp experiments alone, it is difficult to
experimentally dissect whether CaMKII phosphorylation
modulates the rate of CDI, because the increase in subspace
Ca2þ resulting from ICaL and SR Ca
2þ release both activates
CaMKII (and increases mode 2 gating) and inactivates LCCs
(via CDI).
To validate the CaMKII-LCC model against experimental
data and gain insight into the possible role of CaMKII in
A Mechanistic Model of ICaL Facilitation 1777CDI, we performed an analysis of ICaL kinetics from the 1-Hz
pacing protocol described in Fig. 4. It is assumed that in the
experimental data (7,8), LCCs are fully recovered from inac-
tivation at the start of each pulse. To match these conditions,
the results from the 1-Hz pacing protocol simulations were
used in the analysis. At 1-Hz pacing, simulations show that
the entire population of LCCs is recovered from VDI at
the start of each pulse. At 2-Hz pacing, VDI accumulates
(Fig. 4 D), which would make comparison to experimental
results more difficult. Fig. 5, A and B show averaged model
ICaL during the first pulse and the fifth to twentieth pulses,
respectively. The currents are subtracted to zero steady-state
current and normalized to the same peak, to visualize and
compare inactivation kinetics. Fig. 5 A demonstrates that
during the first pulse there is no noticeable difference in
ICaL inactivation kinetics in the presence or absence of
CaMKII. However, as the pulse train progresses and facilita-
tion develops fully (after the fourth pulse; Fig. 4 C), it
becomes apparent that the rate of inactivation in the presence
of CaMKII is slower than that in its absence (Fig. 5 B). To
quantify this difference, the inactivation phase of each ICaL
curve in every simulation (i.e., from 3 ms following the
peak current to steady state) is fit with a single exponential.
Data from the fifth to twentieth pulses from 30 simulations
were averaged both with and without CaMKII. In simula-
tions, in the presence of CaMKII, the average time constant
for inactivation is tCaMKII¼ 29.7 ms 0.27 ms (mean SE)
and, in the absence of CaMKII, tNoCaMKII ¼ 24.6 ms 
0.13 ms. Two-way ANOVA and one-way nonparametric
ANOVA Kruskal-Wallis tests both demonstrated that the
time constants between the model results in the absence and
presence of CaMKII are significantly different (p < 0.0001).
These results are similar to those reported in overexpres-
sion and transgenic mouse experiments (7,8). Whereas the
difference between time constants is significant, it is rela-
tively small (<10 ms) and may not be easily detectable in
experiments that use thapsigargin to diminish facilitation
(19). It should be noted that ICaL simulated in the presence
of CaMKII has an increased time constant of inactivation,
without any modification of the intrinsic rates of voltage-
or Ca2þ-dependent inactivation at the single-channel level.
The shift in macroscopic ICaL kinetics is due to CaMKII
phosphorylated LCCs, which have a higher open probability
than that of mode 1 channels. These results suggest that
CaMKII does not necessarily alter the intrinsic CDI mecha-
nism, contrary to the appearance of decreased inactivation
dynamics in facilitated whole-cell Ca2þ currents.
Recovery curves
Experimental studies in numerous animal models (15,19,20)
have indicated that CaMKII-mediated phosphorylation
modulates LCC recovery from Ca2þ and/or voltage-depen-
dent inactivation. These studies employed a double-pulse
protocol, in which myocytes are depolarized, then hyperpo-larized for a variable length of time, and then depolarized
again. Peak currents during the second pulse were measured
as a function of interpulse interval and were normalized to
either the peak of the current evoked by the first pulse or
the peak of the current evoked on the second pulse after
a sufficiently long interpulse interval.
To validate our model, we performed simulations using
the same double- pulse protocol as that employed by Li
et al. (20) in ferret ventricular myocytes. The SR is loaded
by holding the membrane potential at 70 mV, and then
FIGURE 5 Increase in macroscopic ICaL inactivation time due to shifts in
modal distribution. Data are from the same 1-Hz pacing simulation as that in
Fig. 4, (n ¼ 30 each for each set of simulations). Averaged ICaL from both
sets of simulations are normalized by i) shifting the currents so that steady
state is 0 pA/pF at the end of each depolarization, and then ii) multiplying
the average ICaL so that peak amplitudes are equal to 1 during each pulse.
Results in the presence and absence of CaMKII are presented. (A) Normal-
ized ICaL from the first pulse in the pacing protocol. (B) Normalized ICaL
from the fifth to twentieth pulses in the pacing protocol. The kinetics of
ICaL between the two models are virtually identical in the first pulse;
however, there is a noticeable increase in the apparent inactivation time of
ICaL during the fifth to twentieth pulses.
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imental results. Membrane potential was held at 70 mV,
and then depolarized to 0 mV for 200 ms at 0.5 Hz for 5
pulses to load the SR. After loading, the membrane was
hyperpolarized to 90 mV for 2 s. Then for 500 ms, a de-
polarizing pulse to 0 mV was applied (first pulse), followed
by hyperpolarization to 90 mV for a variable length of
time, followed by another depolarizing pulse to 0 mV
(second pulse). ICaL was measured as the difference
between peak current and the residual current at the end
of the pulse, as in experiments (20), and normalized to
peak ICaL measured after a 10 s inter-pulse interval. Results
in the presence and absence of CaMKII are presented. For
all sets of simulations, n ¼ 30 and bars represent mean 
SE. (A) Average normalized ICaL peaks at different inter-
pulse intervals, in CaMKII-LCC model simulations and
experimental results (20). Solid lines represent simulation
results. Circles represent experimental results in the pres-
ence (KN-93) and absence (control) of CaMKII inhibitor
KN-93. (B) Model simulation results of average percentage
of not-inactivated LCCs as a function of interpulse interval.
(C) Simulation results of the fraction of mode 2 LCCs at
peak ICaL at each interpulse interval. (D) Simulation results
of the fraction of LCCs phosphorylated x times at the start
of the double pulse protocol (x ¼ 0, 1, 2, or 3). (E and F)
Average percent of open LCCs during the second pulse,
at an interpulse interval equal to 1 s (E) or 10 s (F). Solid
lines represent the percent of total open LCCs in simula-
tions in the absence of CaMKII and the percent of total
open LCCs (gating in both modes) in simulations in the
presence of CaMKII. Dashed lines represent the percent
of open, mode 2 gating LCCs in simulations in the presence
of CaMKII. The fraction of open, mode 2 gating LCCs is
much higher after a 1-s interval than after 10 s.depolarizing to 0 mV for 200 ms at 0.5 Hz for five pulses.
After loading, membrane potential is held at 90 mV for 2
s before applying the double-pulse protocol. A 500-ms dura-
tion pulse to 0 mV is followed by an interpulse interval at
90 mV for a variable length of time, followed by another
500-ms depolarizing pulse to 0 mV. ICaL is measured as
the difference between peak current and the residual current
at the end of the pulse, as in experiments (20), and normal-
ized to peak ICaL measured after a 10-s interpulse interval.
Fig. 6 A illustrates the results obtained from simulating this
protocol, superimposed upon experimental data. In simula-
tions and experiments, when CaMKII is present, normalized
peak current rises sharply, overshooting 100% at an inter-
pulse interval of ~300 ms. The normalized peak ICaL maxi-
mizes, then gradually decreases, returning almost to 100%
at an interpulse interval of 3 s. In the absence of CaMKII,
normalized peak ICaL has a steep initial rise to 50–60% at
100 ms, and then gradually increases until it reaches 100%
at an interpulse interval of ~3 s. These results suggest that
CaMKII phosphorylation of LCCs results in an increased
rate of LCC recovery from inactivation; however, further
analysis shows otherwise (see description of Fig. 6 B–F).
Discrepancies between experimental and simulation values
Biophysical Journal 96(5) 1770–1785may stem from the fact that recovery curves differ in their
absolute values among different animal models (15,19,20).
Fig. 6 B presents a plot of the simulated fraction of avail-
able LCCs (i.e., channels that are not Ca2þ- or voltage-inac-
tivated) as a function of interpulse interval. Clearly, whether
CaMKII is absent or present, Ca2þ channels recover from
inactivation at the same rate. This may appear to contradict
the results of Fig. 6 A. However, the lack of effect of CaMKII
in Fig. 6 B is expected, because no changes were made to the
inactivation parameters of the original LCC gating model to
simulate the action of CaMKII. The apparent inconsistencies
between Fig. 6, A and B can be explained by the fact that
CaMKII-phosphorylated channels stay open longer than do
unphosphorylated channels. In the model, because mode 1
LCCs differ from mode 2 LCCs only by their larger closing
rates, mode 2 channels have a significantly higher open prob-
ability than that of mode 1 channels (Fig. 3). Therefore, at the
time of peak ICaL, open probability for the population of
LCCs will increase with the fraction of LCCs that are gating
in mode 2. In the presence of a CaMKII inhibitor, there are
no mode 2 channels and, therefore, a lower overall open
probability of LCCs. The effect of this underlying mecha-
nism on recovery curves can result in the incorrect
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presence versus the absence of CaMKII.
Fig. 6 C shows the averaged fraction of LCCs that are in
mode 2 at the time of peak ICaL during the second pulse. The
curve peaks at 7.2% at an interpulse interval of 300 ms and
decreases to 2.3% at an interval of 10 s. The combination of
mode 2 gating (Fig. 6 C) and recovery from Ca2þ- and
voltage-dependent inactivation (Fig. 6 B) contributes to the
shape of the recovery curve in Fig. 6 A, in which CaMKII
is present (see the Discussion section). Before the double-
pulse protocol, cells undergo pacing to load the SR. This
pacing activates CaMKII and leads to phosphorylation of
LCCs. Fig. 6 D displays the distribution of LCCs partially
and fully phosphorylated at the start of the double-pulse
protocol. At the start of the first pulse, 4% of LCCs are gating
in mode 2, and 66% of LCCs are partially phosphorylated
(44% at one site and 22% at two sites). This initial state
allows the fraction of LCCs in mode 2 to reach values
exceeding 7% during pulse two of the double-pulse protocol
(Fig. 6 C).
Fig. 6 E shows the open fraction of LCCs during pulse two,
averaged over 30 simulations in the presence of CaMKII
(~12% at the time of peak current) and in the absence of
CaMKII (~10% at the time of peak current) when the inter-
pulse interval is 1 s. Mode 2 channels comprise almost one
third of all open channels at peak current when CaMKII is
present. On the other hand, when the interpulse interval is
10 s, most CaMKII has had enough time to return to the inac-
tive state (data not shown) and only a negligible fraction of
LCCs remain phosphorylated (also not shown), leading to
current amplitudes that do not differ in the presence or
absence of CaMKII (Fig. 6 F). This small fraction of mode
2 channels has no significant effect on peak current. Our
simulation results suggest that despite what appear to be
convincing data from double-pulse experiments, it is not
necessary to assume that CaMKII affects intrinsic rates of
recovery of Ca2þ channels. The simpler assumption, that it
promotes the transition of some LCCs from mode 1 to
mode 2, leading to higher channel open probability and
a greater number of open LCCs during peak current, is suffi-
cient to explain the behaviors observed in experimental data.
DISCUSSION
In this study, we have presented a biochemically detailed,
stochastic model of CaMKII activity in the cardiac ventric-
ular myocyte. The model describes CaMKII activity as
a function of Ca2þ levels in the dyad, dynamic phosphoryla-
tion and dephosphorylation of LCCs by CaMKII, and the
functional consequences of these events on voltage- and
Ca2þ- dependent gating of LCCs. This approach makes it
possible to include information on CaMKII-phosphorylated
LCC gating properties derived from single-channel experi-
ments (16), which would otherwise be impossible when
using a more phenomenologic model. The model is used toinvestigate the molecular basis of LCC facilitation, which
is a Ca2þ-dependent augmentation of ICaL, observed in
response to rapid, repeated depolarizing stimuli. Experi-
ments have shown that CaMKII phosphorylation of LCCs
drives the channels into high-activity gating modes (16). It
has also been suggested that an increased rate of recovery
of LCCs from CDI underlies facilitation (15,19,20). In addi-
tion, some experimental studies have shown that CaMKII
overexpression results in decreased ICaL inactivation (7,8),
whereas other studies have demonstrated no effect of CaM-
KII on CDI (19). Modeling results have shown that a broad
range of experimental data on LCC facilitation can be ac-
counted for by assuming that the major effect of CaMKII-
mediated phosphorylation of LCCs is to increase the fraction
gating in mode 2—a gating mode characterized by long
channel open times. In this study, we have shown that a
CaMKII-mediated phosphorylation of LCCs shifts the distri-
bution LCC gating modes in favor of mode 2 channels and
can account for experimentally observed increases in ICaL
amplitude, changes in ICaL inactivation kinetics, and alter-
ations in recovery from inactivation.
Recently, Saucerman andBers (53) have presented amodel
of CaMKII activity as a function of subspace Ca2þ, CaM and
phosphatases. Their major finding was that the different affin-
ities of CaM for CaMKII and calcineurin determine their
sensitivity to local versus global Ca2þ signals in the cardiac
myocyte. In the modeling work described here, we have
examined additional aspects of CaMKII signaling. Specifi-
cally, we have included additional physiologic CaMKII
activity states and have accounted for different activity levels
corresponding to each conformational state. We have also
modeled the interaction between CaMKII and LCCs in the
dyad, to gain an understanding of the mechanisms behind
facilitation. Very importantly, we have studied CaMKII
signaling using a computational model that describes graded,
rather than all or none, release of Ca2þ from RyRs (22). The
ability to describe such graded release is central to modeling
and understanding Ca2þ signaling and regulation of LCCs
in the cardiac dyad. Finally, our simulation results have
been validated against dynamic pacing experimental data.
This gives us confidence in our predictions of CaMKII
activity under various experimental protocols.
Insights provided by model results
Pacing experiments in different animal models have shown
that facilitation can range from 10–50% (12,14–16,20,54).
The CaMKII-LCC model results fit well within this range.
In addition, the time to reach steady-state facilitation varies
among different studies. These variations may be partially
due to the differences in SR Ca2þ uptake and SR Ca2þ
leak among species (55,56). However, the model suggests
that some of this variation can also be attributed to differ-
ences between experimental protocols. If a myocyte is hyper-
polarized (allowed to rest) for a long time before initiation of
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completely unphosphorylated at the start of the first pulse.
On the other hand, if the myocyte is repetitively depolarized
to load the SR before the start of pacing, a significant fraction
of CaMKII is active and some LCCs are already phosphory-
lated when the pacing protocol begins. In this scenario,
a nonzero fraction of mode 2 channels contributes to the
magnitude of ICaL in response to the first pulse, thereby
increasing its peak. Because facilitation is measured as a rela-
tive fractional increase of ICaL with respect to the first
current, an increase in first-pulse ICaL results in the appear-
ance of little-to-no facilitation. In double-pulse protocol
simulations, after the membrane is repeatedly depolarized
to load Ca2þ into the SR, and a subsequent test pulse is deliv-
ered, the fraction of mode 2 LCCs reduces to 0.343% after
a 10-s interpulse interval (data not shown), compared to
6.65% after a 1-s interval, as shown in Fig. 6 C. This is
consistent with the experimental results of Hryshko and
Bers (57), who demonstrated a relationship between postrest
recovery and Ca2þ entry by showing that 10–15 s of rest was
required for fully developed ICaL facilitation to occur. In the
simulations shown in Figs. 4 and 5, the cell is held at the
resting potential for 1 min before pacing. This is similar to
the protocols used in facilitation experiments on rabbit (15)
and rat myocytes (19).
Additionally, model results suggest that time of rest and
Ca2þ entry affect experimental ICaL recovery curves. If
a cell is paced at high frequency before a double-pulse
protocol, a subset of LCCs will be phosphorylated at the
beginning of the first pulse (Fig. 6 D), whereas cells sub-
jected to a long rest period before pacing exhibit little or
no LCC phosphorylation. Therefore, in the former condition
in which pacing occurs before the first pulse, there are likely
to be more LCCs gating in mode 2 by the second pulse, thus
increasing peak current and shifting the recovery curve,
giving it a steeper incline. This idea would explain why, at
physiologic Ca2þ levels, there is an overshoot in recovery
curves from double-pulse experiments preceded by pacing
(20), whereas no overshoot is present when the first pulse
is preceded by a long period of rest (58). This idea appears
to be in disagreement with results from a double-pulse exper-
iment by Guo and Duff (19), who showed that when CaMKII
was present in rat myocytes, preconditioning at a fast (1 Hz)
or slow (0.1 Hz) pacing frequency had no effect on ICaL
recovery. However, in their experiment, the contribution of
SR Ca2þ was eliminated by pretreatment with thapsigargin,
and so it is unclear whether enough CaMKII became acti-
vated to have a significant effect on modal gating distribution
and whether their conclusion can be applied to experiments
in a more physiologic setting.
In the 2-Hz pacing simulation presented in Fig. 4, steady-
state CaMKII autophosphorylation reached ~4% (see Fig. S3
for more details). This value is in accordance with experi-
mental observations by Huke and Bers (40), who reported
negligible levels of autophosphorylated CaMKII during
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CaMKII is bound and unphosphorylated, which would be
impossible to detect using standard CaMKII activity tests
that measure T287-phosphorylation by Western blot anal-
ysis. Therefore, it is possible that actual CaMKII activity is
much higher than what is typically reported in experiments.
Also, if physiologic kinase activity is highly dependent on
local Ca2þ and CaM concentrations, it is possible that CaM-
KII would be rendered inactive under certain patch clamp
protocols, which control the intracellular cytosolic environ-
ment by rupturing the cell membrane, exposing the cytosol
to the pipette solution, and significantly diluting untethered
cellular proteins such as CaM. This may explain why no
facilitation is reported in some pacing experiments (59),
whereas, in other studies that employ perforated patch
clamps (19,20), facilitation is clearly evident.
The model predicts that, during rapid pacing, the late
component of ICaL at the end of each depolarization is signif-
icantly greater when CaMKII is present than when it is absent
(see averaged ICaL curves in Fig. 4). This is a result of the high
open probability of mode 2 channels. In HF, diastolic Ca2þ
(10,60,61) and CaMKII levels (9,10) are higher than normal.
It has been suggested that CaMKII overexpression acts as
a compensatory mechanism for contractile dysfunction.
CaMKII hyperphosphorylates PLB, which increases Ca2þ
uptake into the SR (2,9,10). It is possible that CaMKII over-
expression increases the number of CaMKII molecules that
interact with LCCs in the dyad. A larger fraction of LCCs
would be operating in mode 2 than the fraction under control
conditions. The resulting increase of LCC Ca2þ flux would
increase SR Ca2þ levels by bringing more Ca2þ into the cell
in conjuction with enhanced SR Ca2þ pumping due to PLB
phosphorylation. However, overexpression of CaMKII may
also have proarrhythmic effects in HF, because increased
mode 2 LCC gating activity may increase the likelihood of
EADs (11).
Finally, a first-principles approach was taken in construct-
ing the CaMKII activity model. The activity states C and U
were added to those presented by Dupont et al. (26) to repre-
sent the full range of possible phosphorylation and binding
states of the kinase. It turns out that inclusion of these addi-
tional states leads to only minor changes in the behavior of
CaMKII, because these states are rarely occupied, and their
contribution is small under the experimental protocols that
were employed. Therefore, it may be possible to eliminate
these states in future reduced model versions that simulate
pacing and double-pulse protocols. However, these addi-
tional states may turn out to play an important role in other
experimental protocols that were not studied in the simula-
tions presented here.
The role of protein phosphatases
A number of studies have proposed using phosphatase inhib-
itors to suppress HF (62,63), and others have found that
A Mechanistic Model of ICaL Facilitation 1781overexpression of phosphatases impairs cardiac function
(64). Model simulations indicate that protein phosphatases
play a significant role in modulating LCC gating. PP1 regu-
lates the level of Ca2þ-independent CaMKII levels by de-
phosphorylatingCaMKII site T287. If PP1 levels are reduced,
a higher fraction of CaMKII becomes autophosphorylated
and unresponsive to surrounding Ca2þ levels, which indi-
rectly limits the ability of LCCs to shift modal distribution
in response to changing Ca2þ. Additionally, PP1 targets
a PKA-specific site on the LCC that increases the rate of
channel opening when it is phosphorylated (48). Therefore,
a reduction in PP1 levels would also serve to increase the
number of channel openings and LCC open probability.
Varying PP2A levels in the model has a significant effect
on steady-state LCC mode 2 fraction and ICaL facilitation
during pacing (see Supporting Material). Simulations
suggest that if PP2A phosphatase activity is reduced by
even ~15% (possibly by detachment from LCCs or protein
degradation in experiments), this would lead to an 8–9%
increase in steady-state ICaL facilitation. In addition, PP2A
dephosphorylates a PKA phosphorylation site on LCCs
that is also linked to mode 2 gating (48). A high sensitivity
to PP2A could help explain some of the variation in facilita-
tion results described earlier among different experimental
groups and across species.
Model assumptions and limitations
A fundamental assumption made in the CaMKII-LCC model
was that CaMKIId, the cardiac isoforms of the kinase,
behaves in a manner similar to CaMKIIa, the isoforms
commonly used in vitro experiments. This assumption was
based on the fact that all isoforms share 89–93% sequence
similarity in their catalytic and autoregulatory domains (65).
A study of the enzymatic properties of CaMKII found that
the rate of CaM binding to CaMKII was not significantly
different between the a- and d-isoforms (66). It should be
noted that the same study found that half-maximal CaMKII
autophosphorylation with respect to CaM was higher in
a than in d (222.6 nM vs. 123.7 nM, p < 0.05), but because
physiologic CaM levels in the dyad are significantly higher
than these half-maximal values, the autophosphorylation
rate in the model was not altered to account for the differences
between isoforms.
Experimental results from rabbit (15), ferret (20), and
mouse (16) ventricular myocytes have demonstrated that
facilitation can take place in the presence of EGTA,
a Ca2þ chelator with slow Ca2þ-binding kinetics. Therefore,
it is assumed in the model that the CaMKII phosphorylating
LCCs solely responds to local, rapidly changing dyadic Ca2þ
levels. However, it should be noted that an experiment by
Tseng (58) showed that when EGTA concentration was
reduced from 40 mM to 10 mM, or extracellular Ca2þ was
set above physiologic levels, ICaL recovery curves became
steeper and in some instances displayed overshoot, such aswhen CaMKII activity increases and the fraction of mode 2
channels rises. Therefore, it is possible that in addition to
dyadicCaMKII, cytosolicCaMKII also phosphorylates LCCs.
In the model, it is assumed that spatial constraints do not
play a major role in affecting CaMKII kinetics. However, our
previous studies (52) have demonstrated how packing large
proteins such as RyRs and LCCs in the restricted volume
of the dyad (15 nM  100 nM) may influence properties
of CICR. Whereas the small size of the cardiac dyad is at
odds with the idea that large molecules could interact within
the dyad, coimmunoprecipitation studies have shown that
CaMKII tethers to LCCs (36), and it has been reported that
many other proteins, such as PKA anchoring proteins
(AKAPs), PP2A, PP1, and FK506 binding proteins, are
localized within the dyad (47,67) and there may be local
enrichments of mobile CaM molecules in the vicinity of
each LCC (68). Structural reconstructions from electron
microscopy studies of CaMKII have indicated that the diam-
eter of the holoenzyme ranges from 14 nM to 20 nM and the
height ranges from 10 nM to 20 nM, depending on the
activity of the monomers (34,35). Therefore, it is possible
that a holoenzyme of height 10 nM diffuses into the dyad,
and that spatial constraints prevent the monomers in a holo-
enzyme from all activating at once. The ability of these
proteins to interact and the role of geometric constraints at
play in the confines of the restricted dyadic space is not
well understood and deserves further study.
An important simplifying assumption made by the model
is that protein phosphatase concentration and activity levels
remain constant. However, it is likely that, in vivo, PP1 and
PP2A activity levels change dynamically in the myocyte as
a result of phosphorylation by various kinases, including
CaMKII (69), inhibition by inhibitor-1 and -2 (70–72), and
concentration of metalions such as Mn2þ and Fe2þ (73).
However, sufficient data for modeling the dynamic behavior
of these intersecting signaling pathways that activate or
inhibit PP1 and PP2A is not yet available, so their levels
were set to be constant.
Finally, experimental evidence demonstrates that three
LCC phosphorylation sites are necessary for full facilitation.
In the model, this is represented as an all-or-none phenom-
enon, i.e., there are no functional differences between un-
phosphorylated LCCs and channels that have only one or
two sites phosphorylated. In addition, it was assumed that
all three phosphorylation sites are dephosphorylated by
PP2A at the same rate. Because it has been shown that
PP2A tethers to LCCs (47) and dephosphorylates the mode
2 PKA phosphorylation site, this appears to be a reasonable
assumption, given that there is no other data available. The
decision to equalize the phosphorylation rates of each site
is based on results from a biochemical experiment by White
et al. (46), which reported an optimal substrate recognition
motif for CaMKII. All three of the LCC phosphorylation
sites are contained in amino acid sequences that match the
optimal substrate recognition motif reported in this study.
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CaMKII-LCCmodel simulation results predict that CaMKII-
mediated phosphorylation of LCCs does not affect intrinsic
CDI rates. Zu¨hlke et al. (74) corroborated this claim by
showing that facilitation and CDI are distinct forms of
Ca2þ-dependent LCC regulation in LCC IQ motif mutation
studies in Xenopus oocytes. However, it is unclear how
much influence CaMKII would have exerted in their experi-
mental environment. It would be interesting to test the model
prediction in a more physiologic cardiac setting by applying
the double-pulse protocol to cardiac myocytes with mutated
LCC IQ domains that do not allow CDI. If, as hypothesized,
phosphorylation by CaMKII only affects LCC gating and
does not affect intrinsic CDI, then recovery curves in the pres-
ence and absence of CaMKII should be significantly different.
According to our prediction, the recovery curve will be
steeper for myocytes with uninhibited CaMKII, because of
the higher open probability of CaMKII-phosphorylated
LCCs. This effect should be even more dramatic if myocytes
are paced before the double pulse to load the SR, because there
will be a higher fraction of activeCaMKII and phosphorylated
LCCs at the start of the first pulse.
In this study, we present an original mechanistic model
that examines the local interaction between individual CaM-
KII holoenzymes and LCCs in the context of the cardiac
dyad. The model faithfully replicates single-channel,
whole-cell, and in vitro results, and serves as a powerful
tool for the interpretation of ICaL experiments. However, in
addition to LCCs, CaMKII has many targets in the cardiac
myocyte, including PLB (75–77), RyRs (45,78,79), and
Naþ channels (80). Whereas it is possible that the effects
of CaMKII phosphorylation on other targets may modulate
intracellular ion concentrations and influence ICaL facilita-
tion, we believe that it is important to first understand the
direct interaction between CaMKII and LCCs. Future studies
will concentrate on the interaction between CaMKII and
RyRs in an effort to interpret experimental results.
APPENDIX: STOCHASTIC MODELING
ICaL was modeled in the context of the cardiac myocyte, using an integra-
tive computational model incorporating local control of SR Ca2þ release,
described by Greenstein and Winslow (22). In this model, local interac-
tions of individual sarcolemmal LCCs with nearby RyRs in the JSR
membrane are simulated stochastically, with these local simulations
embedded within the numerical integration of the differential equations
describing ionic and membrane pump/exchanger currents, SR Ca2þ
cycling, and time-varying cytosolic ion concentrations. The stochastic
component of the model was expanded to include CaMKII activity and
interaction with LCCs. The state of each individual CaMKII monomer
is tracked as part of the stochastic simulation. At each time step, the tran-
sition rates from the current state into different states are calculated as
a function of neighboring CaMKII subunit state, subspace Ca2þ, PP1,
PP2A, and CaM concentrations. The time that a CaMKII monomer spends
in each state is exponentially distributed. Over a small time interval tstep,
the probability of a CaMKII monomer exiting state x to enter state y
(ProbXtoY) is approximated by the time step (tstep) multiplied by the tran-
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10% of the inverse of the largest transition rate constant. There are also
additional constraints on the size of tstep based on dyadic Ca
2þ levels,
as described previously (22). The probability that a CaMKII monomer
will leave its current state within tstep is equal to the sum of all exit prob-
abilities from that state (ProbSumExit). The probability of staying in the
current state (Premain) is equal to 1  ProbSumExit. At each time step, for
each CaMKII monomer, a random number u is generated in the interval
[0,1]. The subinterval in which u dwells determines the state that the
monomer will occupy next. Interval lengths correspond to the probability
of entering a particular state.
For example, assume a monomer is in state N, and it can transition to
state N  1 with probability ProbNto(N  1) or state N þ 1 with probability
ProbNto(N þ 1), or it can remain in its current state with probability
1  ProbNto(N  1)  ProbNto(N þ 1). If the random number u falls in the
interval [0, 1  ProbNto(N  1)  ProbNto(N þ 1)], then the monomer will
remain in its current state. Ifu lies in the interval [1ProbNto(N 1)ProbN-
to(N þ 1), 1 ProbNto(N þ 1)], the state will change fromN to N 1. Finally, if
u lies in the interval [1 ProbNto(N þ 1), 1], the state changes fromN to Nþ
1. This type of procedure is used to determine the transitions for all
stochastic components of the ventricular myocyte model (i.e., CaMKII
activity, LCC phosphorylation, LCC gating, RyR gating, and Ito2 gating).
MODEL EQUATIONS
CaMKII activity
The equations for the CaMKII state model are as presented below.
KXToY defines the transition rate from state X to state Y. A list of rate
parameters can be found in Table 3. Most of the rates are identical to
those found in (26); however, the dephosphorylation reactions and the
rates involving states C and U are new, as described earlier. In addition,
a new variable CaMKIIHoloAct is introduced. It describes the average
CaMKII activity among all monomers in the holoenzyme.
KItoU ¼ kIU (1)
KItoB ¼ kIB 

Ca4CaMcleft

(2)
KBtoI ¼ kBI (3)
KBtoP ¼

ActMonOnLeft þ ActMonOnRight
 kBToP  CB
 CaMKII2HoloAct

=

CaMKII2HoloAct þ k2T

;
(4)
where ActMonOnLeft and ActMonOnRight refer to the activity coefficients of the
adjacent CaMKII monomers. (See Supporting Material for details on KBtoP.)
KPtoB ¼ VmaxPP1  ½PP1 (5)
KPtoT ¼ kPT (6)
KTtoP ¼ kTP 

Cacleft
4
(7)
KTtoA ¼ kTA (8)
KAtoT ¼ kAT 

CaMfree

(9)
KAtoC ¼ kAC (10)
KCtoA ¼ 3  VmaxPP2A (11)
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Parameter Value Reference
kIU 6  107 ms1 (42)
[CaM] 0.2 mM (z 20/dyad) (52,68)
kIB 10
5 nM1 ms1 (26)
kBI 8  104 ms1 (26)
kBToP 8  104 ms1 Correspondence with authors of (26)
kT 1.3 Correspondence with authors of (26)
kPT 10
3 ms1 (26)
kTP 10
3 mM4 ms1 (26)
kTA 8  107 ms1 (26)
kAT 10
5 nM1 ms1 (26)
kAC 1.46  104 ms1 (43)
VmaxPP1 1.561  102units substrate  (units PP1)1 ms1 New England Biolabs
[PP1] 5/12 units PP1  (units CaMKII)1 (44,45); and see description of CaMKII-LCC module
VmaxPP2A 1.199  103units substrate  (units PP2A)1 ms1 Gentaur Europe
3 0.6 units PP2A  (units substrate)1 None (see description of CaMKII-LCC module and
Supporting Material)KCtoU ¼ VmaxPP1  ½PP1 (12)
KUtoI ¼ 3  VmaxPP2A (13)
Ca4CaMcleft ¼

CaM
  106
 Ca4cleft

=

Ca4cleft
 þ 1 ð14Þ

Ca4cleft
 ¼ Cacleft
4  1012  note:
Cacleft

is measured in nM
 ð15Þ
CaMKIIHoloAct ¼ 1
12

X12
i¼ 1
ActMonomer i; (16)
where ActMonomer i is the activity coefficient of monomer i, which is a
member of the holoenzyme.
CaMKII-LCC phosphorylation
There are three putative sites on the LCC that are each phosphorylated at the
same rate by CaMKII and dephosphorylated by PP2A. The transition rates
are as follows:
KPhosph ¼ kBtoP  CaMKIIHoloAct (17)
KDephosph ¼ 3  VmaxPP2A: (18)
LCC gating
The details of the canine ventricular myocyte model, including the LCC
gating model, can be found in (22). The only difference between mode 1
and mode 2 channels in the LCC gating model is the channel closing param-
eter g. When LCCs gate in mode 1, g ¼ 2.0 ms1, whereas mode 2 gating
LCCs have a channel closing rate, g ¼ 0.098 ms1.
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